世界の男性不妊症市場2022-2030:検査別(DNA断片化法、酸化ストレス解析、顕微鏡検査)、治療法別、地域別

【英語タイトル】Male Infertility Market Size, Share & Trends Analysis Report By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination), By Treatment, By Region, And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GRV22JL053)・商品コード:GRV22JL053
・発行会社(調査会社):Grand View Research
・発行日:2022年5月12日
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥791,350見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥924,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,190,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
グランドビューリサーチ社は、世界の男性不妊症市場規模が2022年から2030年の間に年平均4.9%成長し、2030年までに59億ドルに達すると予測しています。本調査レポートでは、男性不妊症の世界市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、検査別(DNA断片化法、酸化ストレス解析、顕微鏡検査、精子凝集、その他)分析、治療法別(ART・精索静脈瘤手術、薬物治療)分析、地域別分析、競争分析、推奨事項などを掲載しています。本調査レポートでは、EMD Serono, Inc.、Endo International plc、Sanofi、Bayer Group、SCSA Diagnostics、Andrology Solutions、Halotech DNA SL、Intas Pharmaceuticals Ltd.、Aytu BioScience, Inc.、Cadila Pharmaceuticals、Vitrolifeなどの企業情報が含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の男性不妊症市場規模:検査別(DNA断片化法、酸化ストレス解析、顕微鏡検査、精子凝集、その他)
・世界の男性不妊症市場規模:治療法別(ART・精索静脈瘤手術、薬物治療)
・世界の男性不妊症市場規模:地域別
・競争分析
・推奨事項
❖ レポートの概要 ❖

Male Infertility Market Growth & Trends

The global male infertility market size is expected to reach USD 5.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2022 to 2030. Advancements in diagnostic tests and increasing infertility in males are some of the major factors driving the market for male infertility. In addition, lifestyle-associated diseases causing infertility, rising obesity, and the growing aging population are likely to boost the market growth during the forecast period. In the U.S., one-third of infertility cases are due to female factors, one-third due to male factors, and the remaining one-third of the cases are unknown.

The COVID-19 pandemic had a severe impact on healthcare services. The diagnostic kits and critical medical supplies witnessed growing demand. On the other hand, most elective medical procedures dropped by around 50%. As only emergency medical procedures were allowed during the initial phase of the pandemic, the market observed a decline.

DNA fragmentation technique emerged as the largest test segment in 2021 and is expected to maintain its lead during the forecast period. Increasing adoption in developed countries and high cost due to higher sensitivity and reliable analysis of sperm DNA integrity are the key factors driving the segment. The Assisted Reproductive Technology (ART) and varicocele surgery segment dominated the market for male infertility in 2021 due to its high success rate. Intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) are the most commonly used ARTs.

Partnerships and agreements among key manufacturers are expected to boost the market growth in the coming years. For instance, in July 2019, Vitrolife entered into a collaboration with Prime Tech for the development and exclusive marketing of the Piezo technique for improved Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF globally except Malaysia, Thailand, and Japan. Additionally, Vitrolife will initiate the regulatory approval procedures in various markets for the future commercialization of the technology.

Male Infertility Market Report Highlights

• Based on test, DNA fragmentation technique dominated the market in 2021 and is estimated to witness significant growth over the forecast period due to the higher accuracy of the test

• The oxidative stress analysis test segment is gaining popularity due to the accurate determination of reactive oxygen species. In March 2018, Aytu BioScience, Inc. received registration from COFEPRIS in Mexico for MiOXSYS System, which is used for diagnosing male infertility

• Europe dominated the market in 2021 and is expected to maintain its lead during the forecast period due to high adoption of costlier treatment, strong diagnosis rate, and increased awareness

• Asia Pacific is projected to witness substantial growth over the forecast period owing to increasing investment by several clinics and pharmaceutical companies and growing healthcare expenditure

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Test
1.1.2 Treatment
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective – 1
1.8.2 Objective – 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Test
2.2.2 Treatment
2.2.3 Region
2.3 Competitive Insights
2.4 Male Infertility Market Outlook, 2021
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration Analysis
3.3.2 Market driver analysis
3.3.2.1 High Adoption of Assisted Reproductive Technology (ART)
3.3.2.2 Increasing incidence of infertility
3.3.2.3 Acquisitions, mergers, and partnerships in the market
3.3.2.4 Technological advancements
3.3.3 Market restraint analysis
3.3.3.1 High cost of treatment
3.4 Male Infertility Market: Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
3.5 Clinical Trial Analysis
Chapter 4 Male Infertility Market: Test Analysis
4.1 Male Infertility Test Market Share Analysis, 2021 & 2030
4.2 Male Infertility Test Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2017 – 2030 for the Test Segment
4.3.1 DNA Fragmentation Technique
4.3.1.1 DNA fragmentation technique market, 2017 – 2030 (USD Million)
4.3.2 Oxidative Stress Analysis
4.3.2.1 Oxidative stress analysis market, 2017 – 2030 (USD Million)
4.3.3 Microscopic Examination
4.3.3.1 Microscopic Examination market, 2017 – 2030 (USD Million)
4.3.4 Sperm Agglutination
4.3.4.1 Sperm agglutination market, 2017 – 2030 (USD Million)
4.3.5 Computer Assisted Semen Analysis
4.3.5.1 Computer-assisted semen analysis market, 2017 – 2030 (USD Million)
4.3.6 Sperm Penetration Assay
4.3.6.1 Sperm penetration assay market, 2017 – 2030 (USD Million)
4.3.7 Others
4.3.7.1 Others market, 2017 – 2030 (USD Million)
Chapter 5 Male Infertility Market: Treatment Analysis
5.1 Male Infertility Treatment Market Share Analysis, 2021 & 2030
5.2 Male Infertility Treatment Market: Segment Dashboard:
5.3 Market Size & Forecasts and Trend Analyses, 2017 – 2030 for the Treatment Segment
5.3.1 ART & Varicocele Surgery
5.3.1.1 ART & varicocele surgery market, 2017 – 2030 (USD Million)
5.3.2 Medication
5.3.2.1 Medication market, 2017 – 2030 (USD Million)
Chapter 6 Male Infertility Market: Regional Analysis
6.1 Male Infertility Regional Market Share Analysis, 2021 & 2030
6.2 Male Infertility Regional Market: Segment Dashboard
6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.4 SWOT Analysis, by Region
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 MEA
6.5 Market Size, & Forecasts, and Trend Analysis, 2017 – 2030
6.5.1 North America
6.5.1.1 North America male infertility market, 2017 – 2030 (USD Million)
6.5.1.1.1 U.S.
6.5.1.1.1.1 Regulatory & reimbursement scenario
6.5.1.1.1.2 U.S. male infertility market, 2017 – 2030 (USD Million)
6.5.1.1.2 Canada
6.5.1.1.2.1 Regulatory & reimbursement scenario
6.5.1.1.2.2 Canada male infertility market, 2017 – 2030 (USD Million)
6.5.2 Europe
6.5.2.1 Europe male infertility market, 2017 – 2030 (USD Million)
6.5.2.1.1 U.K.
6.5.2.1.1.1 Regulatory & reimbursement scenario
6.5.2.1.1.2 U.K. male infertility market, 2017 – 2030 (USD Million)
6.5.2.1.2 Germany
6.5.2.1.2.1 Regulatory & reimbursement scenario
6.5.2.1.2.2 Germany male infertility market, 2017 – 2030 (USD Million)
6.5.2.1.3 France
6.5.2.1.3.1 Regulatory & reimbursement scenario
6.5.2.1.3.2 France male infertility market, 2017 – 2030 (USD Million)
6.5.2.1.4 Italy
6.5.2.1.4.1 Regulatory & reimbursement scenario
6.5.2.1.4.2 Italy male infertility market, 2017 – 2030 (USD Million)
6.5.2.1.5 Spain
6.5.2.1.5.1 Regulatory & reimbursement scenario
6.5.2.1.5.2 Spain male infertility market, 2017 – 2030 (USD Million)
6.5.3 Asia Pacific
6.5.3.1 Asia Pacific male infertility market, 2017 – 2030 (USD Million)
6.5.3.1.1 Japan
6.5.3.1.1.1 Regulatory & reimbursement scenario
6.5.3.1.1.2 Japan male infertility market, 2017 – 2030 (USD Million)
6.5.3.1.2 China
6.5.3.1.2.1 Regulatory & reimbursement scenario
6.5.3.1.2.2 China male infertility market, 2017 – 2030 (USD Million)
6.5.3.1.3 India
6.5.3.1.3.1 Regulatory & reimbursement scenario
6.5.3.1.3.2 India male infertility market, 2017 – 2030 (USD Million)
6.5.4 Latin America
6.5.4.1 Latin America male infertility market, 2017 – 2030 (USD Million)
6.5.4.1.1 Brazil
6.5.4.1.1.1 Regulatory & reimbursement scenario
6.5.4.1.1.2 Brazil male infertility market, 2017 – 2030 (USD Million)
6.5.4.1.2 Mexico
6.5.4.1.2.1 Regulatory & reimbursement scenario
6.5.4.1.2.2 Mexico male infertility market, 2017 – 2030 (USD Million)
6.5.5 Middle East and Africa (MEA)
6.5.5.1 MEA male infertility market, 2017 – 2030 (USD Million)
6.5.5.1.1 South Africa
6.5.5.1.1.1 Regulatory & reimbursement scenario
6.5.5.1.1.2 South Africa male infertility market, 2017 – 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
7.2 Vendor Landscape
7.2.1 Strategy Mapping
7.2.2 Launch of New Products
7.2.3 Merger and Acquisition
7.2.4 Product Approvals
7.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Strategic Initiatives)
7.4 Company Profiles
7.4.1 EMD Serono, Inc.
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Endo International plc
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.2.5 SWOT analysis
7.4.3 Sanofi
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.3.5 SWOT Analysis
7.4.4 Bayer Group
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.4.5 SWOT analysis
7.4.5 SCSA Diagnostics
7.4.5.1 Company overview
7.4.5.2 Product benchmarking
7.4.6 Andrology Solutions
7.4.6.1 Company overview
7.4.6.2 Product benchmarking
7.4.7 Halotech DNA SL
7.4.7.1 Company overview
7.4.7.2 Product benchmarking
7.4.7.3 Strategic initiatives
7.4.8 Intas Pharmaceuticals Ltd.
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.8.5 SWOT analysis
7.4.9 Aytu BioScience, Inc.
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product Benchmarking
7.4.9.4 Strategic initiatives
7.4.9.5 SWOT Analysis
7.4.10 Cadila Pharmaceuticals
7.4.10.1 Company overview
7.4.10.2 Product benchmarking
7.4.10.3 Strategic initiatives
7.4.11 Vitrolife
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.11.5 SWOT Analysis
Chapter 8 Recommendations

List of Tables

TABLE 1 List of secondary sources
TABLE 2 North America Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 3 North America Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 4 North America Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 5 U.S. Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 6 U.S. Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 7 Canada Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 8 Canada Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 9 Europe Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 10 Europe Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 11 Europe Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 12 U.K. Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 13 U.K. Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 14 Germany Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 15 Germany Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 16 France Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 17 France Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 18 Italy Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 19 Italy Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 20 Spain Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 21 Spain Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 22 Asia Pacific Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 23 Asia Pacific Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 24 Asia Pacific Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 25 Japan Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 26 Japan Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 27 China Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 28 China Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 29 India Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 30 India Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 31 Latin America Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 32 Latin America Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 33 Latin America Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 34 Brazil Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 35 Brazil Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 36 Mexico Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 37 Mexico Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 38 MEA Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 39 MEA Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 40 MEA Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 41 South Africa Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 42 South Africa Male Infertility market, by treatment, 2017 - 2030 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Male infertility market outlook, 2021 (USD Million)
FIG. 9 Market trends & outlook
FIG. 10 Male infertility market segmentation
FIG. 11 Penetration & growth prospect mapping
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Porter’s five forces analysis
FIG. 15 PESTEL analysis
FIG. 16 Male infertility test market share analysis, 2021 & 2030
FIG. 17 Male infertility test market: Segment dashboard
FIG. 18 DNA fragmentation technique market, 2017 - 2030 (USD Million)
FIG. 19 Oxidative stress analysis market, 2017 - 2030 (USD Million)
FIG. 20 Microscopic examination market, 2017 - 2030 (USD Million)
FIG. 21 Sperm agglutination market, 2017 - 2030 (USD Million)
FIG. 22 Computer assisted semen analysis market, 2017 - 2030 (USD Million)
FIG. 23 Sperm penetration assay market, 2017 - 2030 (USD Million)
FIG. 24 Others market, 2017 - 2030 (USD Million)
FIG. 25 Male infertility treatment market share analysis, 2021 & 2030
FIG. 26 Male infertility treatment market: Segment dashboard
FIG. 27 ART & varicocele surgery market, 2017 - 2030 (USD Million)
FIG. 28 Medication market, 2017 - 2030 (USD Million)
FIG. 29 Male infertility regional market share analysis, 2021 & 2030
FIG. 30 Male infertility regional market: Segment dashboard
FIG. 31 Regional market place: Key takeaways
FIG. 32 SWOT analysis: North America
FIG. 33 SWOT analysis: Europe
FIG. 34 SWOT analysis: Asia Pacific
FIG. 35 SWOT analysis: Latin America
FIG. 36 SWOT analysis: MEA
FIG. 37 North America male infertility market, 2017 - 2030 (USD Million)
FIG. 38 U.S. male infertility market, 2017 - 2030 (USD Million)
FIG. 39 Canada male infertility market, 2017 - 2030 (USD Million)
FIG. 40 Europe male infertility market, 2017 - 2030 (USD Million)
FIG. 41 U.K. male infertility market, 2017 - 2030 (USD Million)
FIG. 42 Germany male infertility market, 2017 - 2030 (USD Million)
FIG. 43 France male infertility market, 2017 - 2030 (USD Million)
FIG. 44 Italy male infertility market, 2017 - 2030 (USD Million)
FIG. 45 Spain male infertility market, 2017 - 2030 (USD Million)
FIG. 46 Asia Pacific male infertility market, 2017 - 2030 (USD Million)
FIG. 47 Japan male infertility market, 2017 - 2030 (USD Million)
FIG. 48 China male infertility market, 2017 - 2030 (USD Million)
FIG. 49 India male infertility market, 2017 - 2030 (USD Million)
FIG. 50 Latin America male infertility market, 2017 - 2030 (USD Million)
FIG. 51 Brazil male infertility market, 2017 - 2030 (USD Million)
FIG. 52 Mexico male infertility market, 2017 - 2030 (USD Million)
FIG. 53 MEA male infertility market, 2017 - 2030 (USD Million)
FIG. 54 South Africa male infertility market, 2017 - 2030 (USD Million)
FIG. 55 Strategy framework
FIG. 56 Male infertility competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2021)

★調査レポート[世界の男性不妊症市場2022-2030:検査別(DNA断片化法、酸化ストレス解析、顕微鏡検査)、治療法別、地域別] (コード:GRV22JL053)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の男性不妊症市場2022-2030:検査別(DNA断片化法、酸化ストレス解析、顕微鏡検査)、治療法別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆